Detail of the session

Type :
SATELLITE SYMPOSIA

Date :
Friday 26^th April 2019

Schedule :
12h45 - 13h45

Session Title :

SY5 - Bristol Myers Squibb Satellite Symposium - A Novel Target in Psoriasis: Selective Oral Inhibition of TYK2

Room :

AUDITORIUM

12h45 - 12h50

Welcome, Introductions, and Opening Discussion
Bruce STROBER - United States

12h50 - 13h00

Exploring the Immunogenetics in Psoriasis: Focus on TYK2
Jonathan BARKER - United Kingdom

13h20 - 13h40

Evolving Oral Treatment Possibilities: Clinical Data of the TYK2 Inhibitor
Bruce STROBER - United States

13h00 - 13h20

Spotlight on TYK2 Inhibition and Biomarkers
Richard WARREN - United Kingdom

13h40 - 13h45

Audience Q&A
Jonathan BARKER - United Kingdom
Bruce STROBER - United States
Richard WARREN - United Kingdom